MedTrace Logo

Cryo Balloon for Residual Barrett's Esophagus

NCT02230410 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2022-02-10

Study results available
· View outcomes & findings →

Summary

This study is being done to see if treating residual Barrett's Esophagus after previously having undergone Radiofrequency ablation or Endoscopic Mucosal resection can be eliminated with focal cryotherapy.

Conditions

  • Barrett's Esophagus

Interventions

DEVICE

CryoBalloon Focal Ablation

Sponsors & Collaborators

  • Pentax Medical

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Kenneth Wang, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-05-26
Completion
2017-05-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02230410 on ClinicalTrials.gov